Crinetics Pharmaceuticals
Price & Volume
Stats
See moreOpen | $35.34 |
Previous Close | $35.86 |
Day Range | $35.12-$36.30 |
52W Range | $24.10-$62.53 |
Market Cap | $3.3B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $1.3M |
Revenue Growth (YoY) | 158.4% |
Gross Profit (12 Mos) | -$244.6M |
Diluted EPS | -$4.10 |
News
See moreYahoo Finance • 6 days ago
Interesting CRNX Put And Call Options For November 21st
Yahoo Finance • 14 days ago
Crinetics Pharmaceuticals Announces September 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last month
Crinetics Receives FDA Orphan Drug Designation for Atumelnant in the Treatment of Congenital Adrenal Hyperplasia (CAH)
Yahoo Finance • last month
Tuesday's pre-market session: top gainers and losers
About
CEO | Dr. R. Scott Struthers Ph.D. |
Address | 6055 Lusk Boulevard, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 437 |
